Knee Arthroplasty, Total Clinical Trial
Official title:
The Effect of Tourniquet Time and Pressure on Intraoperative and Postoperative Performance, Function, Pain, and Complications in Primary Total Knee Arthroplasty.
This proposed novel randomized control trial (RCT) seeks to address this gap in TKA protocol
by gaining a better understanding of the relationship between tourniquet pressure and time,
and intraoperative performance and post-operative outcomes. This study does not seek to
answer the question of "tourniquet vs no tourniquet", but to seek a tourniquet usage that
would maximize the intraoperative benefits for the surgeon and minimize the negative
consequences for patient outcomes.
Specific Aim #1: enroll around 146 primary TKA patients.
Specific Aim #2: evaluate different tourniquet cuff pressures (TCP) and tourniquet times in
relation to intraoperative performance.
Specific Aim #3: evaluate different TCP and tourniquet times in relation to post-operative
pain and complications of short-term, intermediate, and long-term followup.
Specific Aim #4: evaluate different TCP and tourniquet times in relation to post-operative
function of short-term, intermediate, and long-term followup.
The overall goal of the project is to evaluate the relationship of two variables: 1)
tourniquet cuff pressure (TCP); and 2) tourniquet time (i.e. duration of inflation) during
primary TKA relative to three categories of outcomes: 1) intraoperative performance; 2)
post-operative pain and complications; and 3) post-operative complications.
Design
This study will use a randomized controlled trial that is double-blinded. The
co-investigator, Mark Nazal, along with the principal investigator, Dr. Maxwell Langfitt,
will work with the Orthopaedic Clinic Research Coordinator to recruit around 146 patients.
Mark Nazal will then randomize these patients into one of six tourniquet cuff pressure (TCP)
groups:
1. 220 mmHg 4) 300 mmHg
2. 250 mmHg 5) 325 mmHg
3. 275 mmHg 6) 350 mmHg
The primary TKA procedure will be performed by one of the three fellowship-trained orthopedic
surgeons at Wake Forest Baptist Hospital (Dr. Maxwell Langfitt, Dr. Jason Lang, and Dr. John
Shields). The orthopedic surgeon and the patient will be blinded to the TCP assignment and
will not be told what tourniquet pressure is being applied. The OR nursing team will be told
what the patient's assigned TCP is in order to perform the actual inflation.
Data collection will include short-term data: post-operative day 1 (POD1), post-operative day
2 (POD2), and 2-week followup; intermediate data: 6-week and 12-week followup; and long-term
data: 1-year followup.
The data collection for the first category of outcomes, intraoperative performance, will
begin preoperatively, with the recording of baseline characteristics: circumference of the
thigh in centimeters, baseline hemoglobin levels, and thromboembolism risk evaluation.
Intraoperative data will include: the type of anesthesia, the tourniquet size in centimeters,
and whether or not a drain is inserted into the joint. The time of inflation and time of
deflation will be noted in order to determine the duration of tourniquet inflation.
Then preincisional blood pressure (BP) will be measured and will continue to be noted every
15 minutes. At the conclusion of the procedure the surgeon will rate intraoperative
bloodlessness on a four-point scale: 1—bloodless, 2—nearly bloodless, some bleeding;
3—bloody, tourniquet is no better than not using; or 4—venous tourniquet, tourniquet is
making the procedure more difficult. Intraoperative bloodlessness is being used to determine
the functionality and effectiveness of the tourniquet, surgical field visualization, and
surgical site dryness.
The data collection for the second category of outcomes, post-operative pain and
complications, will begin on post-operative day 1 (POD1). Post-operative (post-op) pain will
be assessed using a 0-10 pain rating visual analog scale for both the knee and the thigh, and
will be measured at POD1, POD2, 2-week followup, 6-week followup, 12-week followup, and
1-year followup. Next, wound healing issues will be assessed at POD1, POD2, 2-week followup,
6-week followup, and 12-week followup. Wound healing issues include blisters, wound drainage,
thigh bruising, significant erythema, decreased peripheral pulse, evidence of decreased
distal perfusion, or decreased distal sensation.13 Estimated total blood loss will be
assessed at POD2 using pre-operative Hgb-level compared to Hgb-level on post-op day 2. The
patient's estimated blood volume (EBV) will be calculated using Nadler's formulas for men and
women.16
Then Meunier's formula will be used to calculate estimated blood loss.16 If a drain was
inserted, then the volume of drainage will be measured at POD1. Finally, aseptic loosing of
the implant leading to the need for revision will be assessed at 1-year followup.
The data collection for the third category of outcomes, post-operative function, will begin
at POD1. Ability to ambulate will be measured in distance by feet at POD1 and POD2.
Furthermore, assessment of any use of assisted device for ambulation (wheelchair, walker,
4-point cane, and 1-point cane) will be done at POD1, POD2, 2-week followup, 6-week followup,
12-week followup and 1-year followup. Quadriceps strength and range of motion (ROM) will be
recorded at 2-week followup, 6-week followup, and 12-week followup. Quadriceps strength will
be measured on a 5-point scale, where 0 is no movement and 5 is full strength. ROM will be
measured in degrees of motion. Next, the necessity of performing a manipulation under
anesthesia (MUA) due to limited joint motion will be recorded at 6-week followup and 12-week
followup. The type of PT will be recorded at 2-week followup, 6-week followup, and 12-week
followup. Types of PT include out-patient PT, home health PT, PT rehabilitation, and skilled
nursing facility PT.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04226339 -
Evaluation of Walking Analysis After a Total Knee Arthroplasty With Kinematic Alignment Versus Mechanical Alignment
|
N/A | |
Completed |
NCT03276143 -
FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee Arthroplasty
|
Phase 2 | |
Completed |
NCT03308071 -
Hypnosis for Symptom Management in Elective Orthopedic Surgery
|
N/A | |
Recruiting |
NCT05100706 -
Continuous Adductor Canal Block in Outpatient Total Knee Arthroplasty
|
N/A | |
Completed |
NCT04090125 -
Improving Physical Activity and Gait Symmetry After Total Knee Arthroplasty
|
N/A | |
Recruiting |
NCT04564729 -
Shared Decision Aid for Post-Total Knee Arthroplasty Opioid Prescribing
|
N/A | |
Recruiting |
NCT03695640 -
Effect of Magnesium Sulphate on Analgesia Following Knee Arthroplasty
|
Phase 4 | |
Recruiting |
NCT05877261 -
Cementless Triathlon 5YR Follow-Up
|
||
Recruiting |
NCT05516381 -
Evaluation of Navigation-Assisted TKA Using Mechanical vs. Restricted Kinematic Alignment
|
N/A | |
Completed |
NCT04450485 -
Surgical Approach in Fast Track Knee Arthroplasty
|
N/A | |
Recruiting |
NCT06108063 -
Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan
|
Phase 1/Phase 2 | |
Recruiting |
NCT06389435 -
RObotic-assisted Versus Conventional Knee Endoprosthetic Techniques
|
N/A | |
Completed |
NCT03898544 -
Gait Kinematics After Primary Total Knee Arthroplasty (TKA) Versus Revision TKA
|
||
Completed |
NCT03492320 -
Progression of Health Related Quality of Life of Patients Waiting for Total Knee Arthroplasty
|
||
Active, not recruiting |
NCT02445443 -
LEGION Hinge Safety and Efficacy Study
|
||
Completed |
NCT02186587 -
iTotal Pilot Study of ConforMIS Custom Total Knee Implant
|
N/A | |
Completed |
NCT00711711 -
Manual Lymphatic Drainage Following Total Knee Arthroplasty Surgery
|
N/A | |
Active, not recruiting |
NCT05788757 -
Optetrak Knee System Post Market Clinical Follow-Up
|
||
Completed |
NCT03703206 -
The Analgesic Efficacy of Protocol for Primary Total Knee Arthroplasty (TKA)
|
Phase 3 | |
Completed |
NCT02947321 -
Genicular Radiofrequency Ablation Efficacy in Achieving Total Knee Pain Reduction Trial
|
N/A |